Examining individual BLI data, 50% of mice that did not survive STING therapy developed severe tumor burden in the lung, and similar to isolated hindlimb DMXAA experiments, some mice transiently cleared the lung tumors only to relapse around 3 weeks post-therapy (Figure 3E). The gene discussed is STING1; the disease is medical procedure.